期刊文献+

超声在甲状腺乳头状癌术前分期中的应用价值 被引量:16

Performance of ultrasonography for the preoperative staging of papillary thyroid carcinoma
原文传递
导出
摘要 目的探讨超声在甲状腺乳头状癌术前分期中的应用价值。方法收集2014年1至11月中国医学科学院肿瘤医院经术后病理学检查证实的甲状腺乳头状癌患者121例,共169个病灶。分析肿瘤大小、甲状腺被膜外侵犯范围及颈部淋巴结转移等超声表现,根据国际抗癌联盟(UICC)(第6版)甲状腺癌分期标准行术前分期,并与病理分期对照,评估超声在甲状腺乳头状癌术前分期中的应用价值。结果超声评估甲状腺被膜侵犯的敏感度、特异度、阳性预测值和阴性预测值分别为89.6%(60/67)、72.2%(39/54)、80.O%(60/75)、84.8%(39/46)。术前超声诊断T1~T4正确率分别为75.O%(36/48)、100%(1/1)、81.9%(59,72)、0。超声诊断颈部淋巴结转移的敏感度、特异度、阳性预测值和阴性预测值分别为47.5%(29/61)、90.O%(54/60)、82.9%(29/35)、62.8%(54/86)。结论超声在甲状腺乳头状癌术前分期方面具有较高的应用价值,且有助于判断肿瘤甲状腺外侵犯范围及颈侧部淋巴结转移。 Objective To evaluate the performance of ultrasonography (US) for the preoperative staging of papillary thyroid carcinoma (PTC). Methods One hundred and twenty-one patients with cytologically proven PTC were prospectively collected. Patients were recruited at the Chinese Academy of Medical Sciences Cancer Hospital from January 2014 to November 2014. Preoperative US was performed for the evaluation of primary tumor size, extrathyroidal extension and neck lymph node metastasis according to the 6th UICC TNM staging system. Results The sensitivity, specificity, positive predictive value (PPV) and negative predicative value (NPV) of US in predicting extrathyroidal extension were 89.6% (60/67), 72.2% (39/54), 80.0% (60/75), 84.8% (39/46), respectively. The accuracies of preoperative US for T1, T2, T3, T4 stage were 75.0% (36/48), 100% (1/1), 81.9% (59/72), 0, respectively. The sensitivity, specificity, PPV, and NPV of US in predicting neck lymph node metastasis were 47.5% (29/61), 90.0% (54/60), 82.9% (29/35), 62.8% (54/86), respectively. Conclusion Ultrasonography is a feasible tool for preoperative staging of PTC and is helpful for accurate prediction of extrathyroidal tumor extension and lateral neck lymph node metastasis.
出处 《中华医学超声杂志(电子版)》 CSCD 2015年第5期419-422,共4页 Chinese Journal of Medical Ultrasound(Electronic Edition)
关键词 超声检查 甲状腺肿瘤 肿瘤分期 Ultrasonography Thyroid neoplasms Neoplasm staging
  • 相关文献

参考文献14

  • 1Ito Y, Hiqashiyama T, Takamura Y, et al. Risk factors for recurrence to the lymph node in papillary thyroid carcinoma patients without preoperatively detectable lateral node metastasis: validity of prophylactic modified radical neck dissection[J]. World J Surg, 2007, 31(11): 2085-2091.
  • 2Pelizzo MR, Boschin IM, Toniato A, et al. Papillary thyroid carcinoma: 35-year outcome and prognostic factors in 1858 patients[J]. Clin Nucl Meal, 2007, 32(6): 440-444.
  • 3Ito Y, Miyauchi A, Jikuzono T, et al. Risk factors contributing to a poor prognosis of papillary thyroid carcinoma: validity of UICC/AJCC TNM classification and stage grouping[J]. World J Surg, 2007, 31(4): 838-848.
  • 4Cooper DS, Doherty GM, Haugen BR, et al. Revised American thyroid association management guidelines for patients with thyroid nodules and differentiated thyroid cancer[J]. Thyroid, 2009, 19(11): 1167-1214.
  • 5Sipos JA. Advances in ultrasound for the diagnosis and management of thyroid cancer[J]. Thyroid, 2009, 19(12): 1363-1372.
  • 6Shaha AR. TNM classification of thyroid carcinoma[J]. World J Surg, 2007, 31(5): 879-887.
  • 7Back HJ, Kim DW, Ryu JH. Association between TNM staging system and histopathological features in patients with papillary thyroid carcinoma[J]. Endocrine, 2015, 48(2): 589-594.
  • 8Kwak JY, Kim EK, Youk JH, et al. Extrathyroid extension of well- differentiated papillary thyroid microcarcinoma on US[J]. Thyroid, 2008,18(6): 609-614.
  • 9Ito Y, Miyauchi A, Kihara M, et al. Prognostic values of clinical lymph node metastasis and macroscopic extrathyroid extension in papillary thyroid carcinoma[J]. Endocr J, 2014, 61(8): 745-750.
  • 10Park JS, Son KR, Na DG, et al. Performance of preoperative sonographic staging of papillary thyroid carcinoma based on the Sixth edition of the AJCC/UICC[J]. AJR, 2009, 192(1):66-72.

二级参考文献14

  • 1Ito Y, Hiqashiyama T, Takamura Y, et al. Risk factors for recurrence to the lymph node in papillary thyroid carcinoma patients without preoperatively detectable lateral node metastasis: validity of prophylactic modified radical neck dissection[J]. World J Surg, 2007, 31(11): 2085-2091.
  • 2Pelizzo MR, Boschin IM, Toniato A, et al. Papillary thyroid carcinoma: 35-year outcome and prognostic factors in 1858 patients[J]. Clin Nucl Meal, 2007, 32(6): 440-444.
  • 3Ito Y, Miyauchi A, Jikuzono T, et al. Risk factors contributing to a poor prognosis of papillary thyroid carcinoma: validity of UICC/AJCC TNM classification and stage grouping[J]. World J Surg, 2007, 31(4): 838-848.
  • 4Cooper DS, Doherty GM, Haugen BR, et al. Revised American thyroid association management guidelines for patients with thyroid nodules and differentiated thyroid cancer[J]. Thyroid, 2009, 19(11): 1167-1214.
  • 5Sipos JA. Advances in ultrasound for the diagnosis and management of thyroid cancer[J]. Thyroid, 2009, 19(12): 1363-1372.
  • 6Shaha AR. TNM classification of thyroid carcinoma[J]. World J Surg, 2007, 31(5): 879-887.
  • 7Back HJ, Kim DW, Ryu JH. Association between TNM staging system and histopathological features in patients with papillary thyroid carcinoma[J]. Endocrine, 2015, 48(2): 589-594.
  • 8Kwak JY, Kim EK, Youk JH, et al. Extrathyroid extension of well- differentiated papillary thyroid microcarcinoma on US[J]. Thyroid, 2008,18(6): 609-614.
  • 9Ito Y, Miyauchi A, Kihara M, et al. Prognostic values of clinical lymph node metastasis and macroscopic extrathyroid extension in papillary thyroid carcinoma[J]. Endocr J, 2014, 61(8): 745-750.
  • 10Park JS, Son KR, Na DG, et al. Performance of preoperative sonographic staging of papillary thyroid carcinoma based on the Sixth edition of the AJCC/UICC[J]. AJR, 2009, 192(1):66-72.

共引文献15

同被引文献134

  • 1吕珂,姜玉新,张缙熙,程玉芳,孙影.甲状腺结节的超声诊断研究[J].中华超声影像学杂志,2003,12(5):28-31. 被引量:240
  • 2牛丽娟,王勇,朱利,郝玉芝,周纯武.彩超诊断甲状腺癌颈部淋巴结转移的临床价值[J].中华肿瘤防治杂志,2007,14(14):1100-1101. 被引量:47
  • 3林僖,李安华,赖非云,韩峰,陈芳.甲状腺超声造影及定量分析的优化方法学研究[J].中国超声医学杂志,2007,23(7):496-498. 被引量:19
  • 4王利英,王涌,秦茜淼,王怡(校).超声在淋巴结诊断中的应用[J].上海医学影像,2007,16(3):258-261. 被引量:13
  • 5Ito Y, Hiqashiyama T, Takamura Y, et al. Risk factors for recurrence to the lymph node in papillary thyroid carcinoma patients without preoperatively detectable lateral node metastasis: validity of prophylactic modified radical neck dissection[J]. World J Surg, 2007, 31(11): 2085-2091.
  • 6Pelizzo MR, Boschin IM, Toniato A, et al. Papillary thyroid carcinoma: 35-year outcome and prognostic factors in 1858 patients[J]. Clin Nucl Meal, 2007, 32(6): 440-444.
  • 7Ito Y, Miyauchi A, Jikuzono T, et al. Risk factors contributing to a poor prognosis of papillary thyroid carcinoma: validity of UICC/AJCC TNM classification and stage grouping[J]. World J Surg, 2007, 31(4): 838-848.
  • 8Cooper DS, Doherty GM, Haugen BR, et al. Revised American thyroid association management guidelines for patients with thyroid nodules and differentiated thyroid cancer[J]. Thyroid, 2009, 19(11): 1167-1214.
  • 9Sipos JA. Advances in ultrasound for the diagnosis and management of thyroid cancer[J]. Thyroid, 2009, 19(12): 1363-1372.
  • 10Shaha AR. TNM classification of thyroid carcinoma[J]. World J Surg, 2007, 31(5): 879-887.

引证文献16

二级引证文献120

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部